|
Wed, 12/28/2022 - 19:21 |
Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes |
BioAffinity Tec... |
|
Thu, 12/22/2022 - 08:24 |
UTSW researchers map activity of inherited gene variants linked to prostate cancer |
UTSouthwestern |
|
Fri, 12/16/2022 - 19:15 |
FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer |
FDA |
|
Mon, 12/12/2022 - 16:00 |
City of Hope Study Finds That Neuroendocrine Cancer Patients and Doctors Agree on Treatment Goals Only Half of the Time |
City of Hope Na... |
|
Wed, 12/07/2022 - 10:59 |
Fox Chase Researcher Receives American Cancer Society Grant to Study Synthetic Targets for Tumor Drug Delivery |
Fox Chase Cance... |
|
Thu, 12/01/2022 - 11:19 |
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting |
BioAffinity Tec... |
|
Wed, 11/30/2022 - 18:43 |
New Treatment Strategy Could Boost Efficacy of Immunotherapy in Patients With Solid Tumors |
Roswell Park Ca... |
|
Wed, 11/30/2022 - 12:06 |
Roswell Park, Genome Protection Inc. Team Discovers How Retrotransposons Fuel Drug Resistance in Tumors |
Roswell Park Ca... |
|
Wed, 11/23/2022 - 14:09 |
World first clinical trial in 'man's best friend' could unlock treatment breakthrough for kids with cancer |
UWA |
|
Tue, 11/15/2022 - 12:34 |
Two Fox Chase Researchers Receive Grants to Pursue Innovative Kidney Cancer Research |
Fox Chase Cance... |
|
Tue, 11/08/2022 - 04:04 |
Covid vaccination improves effectiveness of cancer treatment |
BonnUniv |
|
Thu, 10/27/2022 - 17:51 |
Ludwig Chicago nanotechnology induces therapeutic immune responses against multiple types of tumors in preclinical studies |
Ludwig Cancer R... |
|
Wed, 10/26/2022 - 00:19 |
The American Cancer Society & Flatiron Health Announce Recipients of Third Annual Real-World Data Impact Award |
Flatiron Health |
|
Mon, 10/24/2022 - 21:48 |
bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia |
BioAffinity Tec... |
|
Mon, 10/24/2022 - 17:03 |
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy |
Varian Medical ... |
|
Wed, 10/19/2022 - 07:03 |
Cancer Center Announces First Patient Has Received City of Hopes Novel, Potentially Cancer-Stopping Pill |
City of Hope Na... |
|
Wed, 10/05/2022 - 16:17 |
New gene target for aggressive lung cancer discovered |
Northwestern Un... |
|
Tue, 10/04/2022 - 19:17 |
Cancer Research Institute's Spanish-Language Virtual Immunotherapy Patient Summit Now Available On Demand to Help Close the Information Gap for Hispanic Cancer Patients |
Cancer Research... |
|
Fri, 09/30/2022 - 15:57 |
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics |
Gilead Sciences |
|
Mon, 09/26/2022 - 16:09 |
Icon Group and Varian Collaborate on an International HyperArc Registry to Advance Treatment of Brain Tumors |
Varian Medical ... |
|
Thu, 09/15/2022 - 08:47 |
Study Finds New Synthetic Lethal Agent Could Be Potential Treatment for Pancreatic Cancer |
Fox Chase Cance... |
|
Tue, 09/06/2022 - 11:06 |
Cancer Research Institute to Host Second Annual Spanish-Language Virtual Immunotherapy Patient Summit |
Cancer Research... |
|
Fri, 09/02/2022 - 06:14 |
RaySearch and Leo Cancer Care join forces to enable upright radiotherapy |
RaySearch |
|
Sun, 08/28/2022 - 20:31 |
Specific Components of the Tumor Immune Microenvironment May Affect the Durability of Responses to BCMA CAR T-cell Therapy |
American Associ... |
|
Wed, 08/10/2022 - 08:38 |
City of Hope Researchers Have Developed a Blood Test That May Screen for Early-onset Colorectal Cancer |
City of Hope Na... |
